TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7826654

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia (WBC) intermittently every 15 min; clamp time range: 50-140 min
Number of subjects: 76

Group type: COMPARATOR
Intervention: Cold blood cardioplegia (CBC) intermittently every 15 min; clamp time range: 50-140 min
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia (WBC) intermittently every 15 min
Number of subjects: 76
Study: 3413910

Group type: EXPERIMENTAL
Intervention: Twenty-four-hour catheterization perioperatively
Number of subjects: 77

Group type: COMPARATOR
Intervention: Straight catheterization postoperatively in the recovery room
Number of subjects: 77
Study: 29880036

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27842707

Group type: EXPERIMENTAL
Intervention: Propofol 0.2 mg.kg-1 followed by infusion at a rate of 2 mg.kg-1.h-1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ketamine continuous infusion at 0.5 mg.kg-1.h-1
Number of subjects: 30
Study: 26147842

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) exercise group
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 206
Study: 24237777

Group type: EXPERIMENTAL
Intervention: 2-OCA tissue adhesive
Number of subjects: 29

Group type: COMPARATOR
Intervention: Subcuticular sutures
Number of subjects: 29
Study: 21128827

Group type: EXPERIMENTAL
Intervention: Cheonggukjang (CH) 20g/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Red ginseng cheonggukjang (RGCH) 20g/day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (starch 2g/day)
Number of subjects: 45
Study: 19925721

Group type: EXPERIMENTAL
Intervention: Night-time sleep facilitating cereal (225 mg tryptophan, 5.3 mg adenosine‐5'‐P, 6.3 mg uridine‐5'‐P per 100 g)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Night-time sleep facilitating cereal with standard formula milk
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Night-time sleep facilitating cereal with enriched night milk (480 mg tryptophan, 8.8 mg uridine‐5'‐P, 7.6 mg adenosine‐5'‐P per 100 g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard cereal (75 mg tryptophan/100 g product without nucleotides)
Number of subjects: 30
Study: 16516851

Group type: EXPERIMENTAL
Intervention: Monocytes stimulated with A23187+PMA for 1 day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monocytes from volunteers with -137G/G genotype
Number of subjects: 0
Study: 14579088

Group type: EXPERIMENTAL
Intervention: 99mTc-HMPAO SPET
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 99mTc-ECD SPET
Number of subjects: 84
Study: 11938804

Group type: EXPERIMENTAL
Intervention: Shenning Mixture (SNM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prednisone (Control)
Number of subjects: 100
Study: 9346455

Group type: EXPERIMENTAL
Intervention: Self-administered previsit questionnaire
Number of subjects: 201
Study: 8456141

Group type: EXPERIMENTAL
Intervention: Mobilization and extension (experimental group, n = 14)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Flexion exercise regimen (comparison group, n = 10)
Number of subjects: 24
Study: 3942667

Group type: EXPERIMENTAL
Intervention: General anaesthesia plus extradural blockade (Bupivacaine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: General anaesthesia (Control)
Number of subjects: 10
Study: 31611612

Group type: EXPERIMENTAL
Intervention: Elective neck dissection (END)
Number of subjects: 250
Study: 29680419

Group type: EXPERIMENTAL
Intervention: Green Bright Light Therapy (∼507 nm) and Sedentary Activity (sitting, watching TV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Green Bright Light Therapy (∼507 nm) and Morning Activity (standing, playing motion-sensing videogame)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Red Light Therapy (∼643 nm) and Sedentary Activity (sitting, watching TV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Red Light Therapy (∼643 nm) and Morning Activity
Number of subjects: 60

Group type: COMPARATOR
Intervention: All treatment groups combined
Number of subjects: 60
Study: 24997005

Group type: EXPERIMENTAL
Intervention: EPA-rich oil capsules
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: DHA-rich oil capsules
Number of subjects: 94
Study: 22424078

Group type: EXPERIMENTAL
Intervention: WEB (telepsychiatry)
Number of subjects: 167
Study: 20547037

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 1294

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 1294
Study: 17057418

Group type: EXPERIMENTAL
Intervention: Hospital admission
Number of subjects: 50

Group type: COMPARATOR
Intervention: Outpatient assessment
Number of subjects: 50
Study: 16450852

Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reference treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12413779

Group type: EXPERIMENTAL
Intervention: Lifestyle interventions (diet change and increased physical activity)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Diet plus exercise interventions
Number of subjects: 284
Study: 9535150

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure reading of 140 mmHg or more before 20 weeks' gestation
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Body mass index, platelet angiotensin II binding site density, urinary calcium:creatinine ratio measured before 20 weeks gestation
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Blood pressure measurements at 28 weeks of pregnancy
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Plasma angiotensinogen concentration at 28 weeks of pregnancy
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Transient, presumed 'white-coat', systolic hypertension at the first pregnancy visit
Number of subjects: 212
Study: 7632131

Group type: EXPERIMENTAL
Intervention: Current-modulated electrical stimulation through the medial collateral ligament (MCL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Current-modulated electrical stimulation through the lateral collateral ligament (LCL)
Number of subjects: 11
Study: 2173168

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (1 x 1.500 aPTT units plus 2 x placebo injections)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Low dose conventional heparin (3 x 5.000 IU)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 166

Group type: COMPARATOR
Intervention: Low dose conventional heparin
Number of subjects: 166
Study: 699483

Group type: EXPERIMENTAL
Intervention: Diazepam (30 mg) injected intravenously during uterine contractions (Group I)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Diazepam (30 mg) injected intravenously in the relaxation period (Group II)
Number of subjects: 33
Study: 30739558

Group type: EXPERIMENTAL
Intervention: Sequential strategy (LV5FU2 followed by FOLFOX6)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Combination strategy (FOLFOX6 followed by FOLFIRI)
Number of subjects: 407
Study: 27696793

Group type: EXPERIMENTAL
Intervention: Rheumates@Work internet-based program supplemented with 4 group sessions
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 26390700

Group type: EXPERIMENTAL
Intervention: 252Cf neutron brachytherapy (700‐800 cGy doses at point A, once a week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Neoadjuvant intra‐arterial embolism chemotherapy (bleomycin, carboplatin, and cyclophosphamide, twice)
Number of subjects: 32
Study: 23164313

Group type: EXPERIMENTAL
Intervention: Large neutral amino acid (LNAA) supplementation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 22151296

Group type: EXPERIMENTAL
Intervention: NVA237 50 μg once daily
Number of subjects: 822

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 822
Study: 18584897

Group type: EXPERIMENTAL
Intervention: CPC (circulating progenitor cells)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Inactive serum (control)
Number of subjects: 28
Study: 17374034

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study: 15713722

Group type: EXPERIMENTAL
Intervention: 50 mg nandrolone decanoate
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 100 mg nandrolone decanoate
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 150 mg nandrolone decanoate
Number of subjects: 54
Study: 11921498

Group type: EXPERIMENTAL
Intervention: 300 mg metadoxine (given intravenously) added to standard treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 52
Study: 10619926

Group type: EXPERIMENTAL
Intervention: Human serum protein (HSP) 5%
Number of subjects: 24

Group type: COMPARATOR
Intervention: Human albumin (HA) 5%
Number of subjects: 24
Study: 9055913

Group type: EXPERIMENTAL
Intervention: Growth-promoting treatment
Number of subjects: 28
Study: 2031602

Group type: EXPERIMENTAL
Intervention: Artificial surfactant (ALEC)
Number of subjects: 294
Study: 7033015

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg suppository
Number of subjects: 40

Group type: COMPARATOR
Intervention: Indomethacin 100 mg suppository
Number of subjects: 40
Study: 31174888

Group type: EXPERIMENTAL
Intervention: Socially Supportive Activities Program (SSAP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 28166787

Group type: EXPERIMENTAL
Intervention: Protected Mealtimes intervention
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control
Number of subjects: 149
Study: 26458872

Group type: EXPERIMENTAL
Intervention: unguided web‐based self‐help for problematic drinking
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: adherence‐focused guided self‐help
Number of subjects: 528

Group type: COMPARATOR
Intervention: waiting list control
Number of subjects: 528
Study: 22419369

Group type: EXPERIMENTAL
Intervention: rhPTH (1‐34) (20 μg, once-daily subcutaneous injection)
Number of subjects: 124

Group type: COMPARATOR
Intervention: elcatonin (200 U, once-weekly intramuscular injection)
Number of subjects: 124
Study: 21273395

Group type: EXPERIMENTAL
Intervention: Liraglutide 0.6 mg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.2 mg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 19585577

Group type: EXPERIMENTAL
Intervention: Positive Mel‐18 expression
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Homozygous G allele genotype
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Negative Mel‐18 expression
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: G allele
Number of subjects: 393
Study: 17227787

Group type: EXPERIMENTAL
Intervention: Fibrinolysis
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Primary Angioplasty
Number of subjects: 1017
Study: 15381586

Group type: EXPERIMENTAL
Intervention: Intravenous access
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intravenous access
Number of subjects: 100
Study: 12364845

Group type: EXPERIMENTAL
Intervention: Go/NoGo task
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: fMRI data analysis
Number of subjects: 19
Study: 10518849

Group type: EXPERIMENTAL
Intervention: Herbal Toothpaste and Gum Therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Colgate Total
Number of subjects: 40
Study: 8125413

Group type: EXPERIMENTAL
Intervention: 5 mg Parlodel SRO
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2.5 mg Parlodel b.i.d.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 mg Parlodel SRO (single dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 10 mg Parlodel (two doses of 5 mg)
Number of subjects: 20
Study: 2570001

Group type: EXPERIMENTAL
Intervention: 8 mg acrivastine three times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acrivastine and Placebo
Number of subjects: 0
Study: 70149

Group type: EXPERIMENTAL
Intervention: Prednisolone (maintenance dose 15 mg/day)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Corticotrophin (maintenance dose 1 mg/week, i.m.)
Number of subjects: 54
Study: 31544345

Group type: EXPERIMENTAL
Intervention: Intensive Behavioral Therapy (IBT) protocol
Number of subjects: 50
Study: 28623944

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) that includes spinal manipulative therapy (SMT) plus standardised exercise program
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standardised exercise program
Number of subjects: 202
Study: 25527253

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 23414061

Group type: EXPERIMENTAL
Intervention: Mesalazine 1000 mg three times daily
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 21675064

Group type: EXPERIMENTAL
Intervention: Sedation with propofol infusion (10 to 20 mg x hour), n = 20
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: General anaesthesia using sub minimum alveolar concentration of sevoflurane, n = 20
Number of subjects: 40

Group type: COMPARATOR
Intervention: Beachchair positioning during general anaesthesia
Number of subjects: 40
Study: 19368793

Group type: EXPERIMENTAL
Intervention: 4microg Trivalent influenza DNA vaccine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 2microg Trivalent influenza DNA vaccine plus DEI‐LT
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 16940406

Group type: EXPERIMENTAL
Intervention: Orlistat 60 mg, given 3 times daily
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study: 14690727

Group type: EXPERIMENTAL
Intervention: Biatrial synchronous pacing (BAP) for 72 h postoperatively (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No atrial pacing (controls; n=40)
Number of subjects: 80
Study: 11351931

Group type: EXPERIMENTAL
Intervention: Active alcoholics
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Currently abstinent alcoholics
Number of subjects: 46

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Alcohol rewards
Number of subjects: 46
Study: 8988820

Group type: EXPERIMENTAL
Intervention: Midazolam (M)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol (P)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 8100044

Group type: EXPERIMENTAL
Intervention: 200 mg modafinil b.i.d.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3574692

Group type: EXPERIMENTAL
Intervention: Ciladopa (added to levodopa)
Number of subjects: 31
Study: 29316004

Group type: EXPERIMENTAL
Intervention: CMAC videolaryngoscope
Number of subjects: 64

Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 64
Study: 27262412

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 23965000

Group type: EXPERIMENTAL
Intervention: mTBI patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: HC
Number of subjects: 30
Study: 23774725

Group type: EXPERIMENTAL
Intervention: Neurofeedback combined with conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 0
Study: 20221770

Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB) as mono- or add-on therapy, flexible-dosage, administered twice daily
Number of subjects: 187

Group type: COMPARATOR
Intervention: Non-Pregabalin therapy (change established doses and combinations of pre-existing mono- or combination therapy)
Number of subjects: 187
Study: 18677810

Group type: EXPERIMENTAL
Intervention: Fengweicao Granule (FWCG), 5 g orally twice a day for 3 months
Number of subjects: 155

Group type: COMPARATOR
Intervention: Proscar, 5 mg per day for 3 months
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Both groups (FWCG and Proscar)
Number of subjects: 155
Study: 16911387

Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate ointment (Daivobet/Dovobet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcipotriol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ointment vehicle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efalizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alefacept
Number of subjects: 0
Study: 12930031

Group type: EXPERIMENTAL
Intervention: Patient counseling on drug, diseases, and lifestyle modification from a pharmacist after a hospital visit.
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patient counseling
Number of subjects: 78
Study: 12243720

Group type: EXPERIMENTAL
Intervention: Foot orthosis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Heel wedge
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal footwear
Number of subjects: 12
Study: 9776857

Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in keratinocytes at the edge of the wounds
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in proliferative keratinocytes and hair follicles
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in granulation tissue
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Inducible nitric oxide synthase expression in association with inflammatory infiltrates
Number of subjects: 29

Group type: COMPARATOR
Intervention: Noninjured skin
Number of subjects: 29
Study: 8068968

Group type: EXPERIMENTAL
Intervention: Mark-sheet method (MSM)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Manual method (MM)
Number of subjects: 463
Study: 3073356

Group type: EXPERIMENTAL
Intervention: Legalon (MADAUS, FRG) t.i.d. for 30 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 200
Study: 31952367

Group type: EXPERIMENTAL
Intervention: Orthodontic forces applied using a closed-coil spring for 2 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthodontic forces applied using a closed-coil spring for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthodontic forces applied using a closed-coil spring for 14 days
Number of subjects: 0
Study: 31074205

Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study: 29133282

Group type: EXPERIMENTAL
Intervention: Web 2.0 intervention
Number of subjects: 1328

Group type: COMPARATOR
Intervention: Web 1.0 intervention
Number of subjects: 1328

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1328
Study: 25048668

Group type: EXPERIMENTAL
Intervention: Extra PE (four extra physical education lessons per week)
Number of subjects: 1247

Group type: COMPARATOR
Intervention: Normal PE (control group)
Number of subjects: 1247
Study: 23542898

Group type: EXPERIMENTAL
Intervention: Human apoC‐III antisense drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20796260

Group type: EXPERIMENTAL
Intervention: Optyse lens‐free ophthalmoscope
Number of subjects: 20

Group type: COMPARATOR
Intervention: Keeler pocket ophthalmoscope
Number of subjects: 20
Study: 20092085

Group type: EXPERIMENTAL
Intervention: Standard clinical CPB circuits with EDAC system probes
Number of subjects: 12
Study: 16641119

Group type: EXPERIMENTAL
Intervention: Current smokers (n = 35)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Ex-smokers (n = 75)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Snus (oral moist snuff) consumption (n = 21) in ex-smokers
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Passive smoking
Number of subjects: 221

Group type: COMPARATOR
Intervention: Current smoking
Number of subjects: 221
Study: 14964926

Group type: EXPERIMENTAL
Intervention: Office reminder systems (flowsheets with mammography prompts, nonphysician staff identification, computerized reminder systems)
Number of subjects: 24030

Group type: COMPARATOR
Intervention: Urban practices
Number of subjects: 24030
Study: 11718043

Group type: EXPERIMENTAL
Intervention: Quantitative culture (QC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Qualitative routine culture (RC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inappropriate initial empirical antibiotic treatment
Number of subjects: 31
Study: 9254255

Group type: EXPERIMENTAL
Intervention: Liposomes with antibiotics and ectericide
Number of subjects: 120
Study: 8129908

Group type: EXPERIMENTAL
Intervention: Engerix B (SK&F)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Recombivax HB (MSD)
Number of subjects: 640

Group type: COMPARATOR
Intervention: One type of vaccine
Number of subjects: 640
Study: 2447056

Group type: EXPERIMENTAL
Intervention: Chlormadinone acetate (CMA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31479015

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28720395

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination of ACZ and NAC
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 25962400

Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 80
Study: 23237605

Group type: EXPERIMENTAL
Intervention: 0.01 mg.kg(‐1) penehyclidine hydrochloride
Number of subjects: 920

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 920
Study: 21753869

Group type: EXPERIMENTAL
Intervention: Weight loss plus exercise (WL+E)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 34
Study: 19426555

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) levels between 0 and 15 cmH2O
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) levels
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Repeated measurements of lung sounds
Number of subjects: 35